|
⚲
|
| Keyboard |
| Astrazeneca PLC
✚
|
|
|---|---|
| CIK # | 0000901832 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0000901832] | |
| 4 | [0000901832] | |
| 6-K | [0000901832] | |
| SC 13D | [0000901832] | |
| SC 13G | [0000901832] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Viela Bio Inc VIE
Common Stock
|
2021-03-15 | Tender | 14,650,334 | $53.00 | 776,467,702 |
|
Medgenics Inc GNMX
Common Stock
|
2019-12-19 | Buy | 12,946,900 | ||
|
Viela Bio Inc VIE
Common Stock
|
2019-10-07 | Buy | 425,000 | $19.00 | 8,075,000 |
|
Viela Bio Inc VIE
Common Stock
|
2019-10-07 | Conversion | 14,225,324 | ||
|
Viela Bio Inc VIE
Series A-1 Preferred Stock · derivative
|
2019-10-07 | Conversion | 14,225,324 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Conversion | 2,404,554 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Option exercise | 113,891 | $0.12 | 13,667 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Buy | 600,000 | $5.00 | 3,000,000 |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Conversion | 1,664,217 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Sell | 2,734 | $5.00 | 13,670 |
|
PhaseBio Pharmaceuticals Inc PHAS
Warrants to Purchase Series C-1 Preferred Stock · derivative
|
2018-10-22 | Option exercise | 113,891 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series D Preferred Stock · derivative
|
2018-10-22 | Conversion | 740,337 | $0.00 | |
|
Entasis Therapeutics Holdings Inc ETTX
Common Stock
|
2018-09-28 | Buy | 246,666 | $15.00 | 3,699,990 |
|
Entasis Therapeutics Holdings Inc ETTX
Common Stock
|
2018-09-28 | Conversion | 1,918,185 | ||
|
Entasis Therapeutics Holdings Inc ETTX
Series A Preferred Stock · derivative
|
2018-09-28 | Conversion | 33,499,900 | $0.00 | |
|
Albireo Pharma Inc ALBO
Common Stock, $0.01 par value per share
|
2017-12-01 | Sell | 500,000 | $21.40 | 10,700,000 |
|
Regulus Therapeutics Inc RGLS
COMMON STOCK
|
2014-11-12 | Sell | 2,000,000 | $17.00 | 34,000,000 |